Los Angeles Capital Management LLC Takes $7.29 Million Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

Los Angeles Capital Management LLC acquired a new position in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 179,184 shares of the real estate investment trust's stock, valued at approximately $7,293,000. Los Angeles Capital Management LLC owned approximately 0.07% of Omega Healthcare Investors at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of the stock. Vanguard Group Inc. raised its holdings in shares of Omega Healthcare Investors by 0.5% during the 1st quarter. Vanguard Group Inc. now owns 35,379,787 shares of the real estate investment trust's stock worth $1,120,478,000 after acquiring an additional 165,105 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Omega Healthcare Investors by 7.9% in the second quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust's stock worth $127,831,000 after buying an additional 272,299 shares during the period. Bank of New York Mellon Corp lifted its stake in shares of Omega Healthcare Investors by 4.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 3,240,025 shares of the real estate investment trust's stock worth $110,971,000 after acquiring an additional 143,521 shares during the last quarter. LSV Asset Management boosted its holdings in Omega Healthcare Investors by 0.7% during the 2nd quarter. LSV Asset Management now owns 1,968,200 shares of the real estate investment trust's stock valued at $67,411,000 after acquiring an additional 14,000 shares during the period. Finally, Assetmark Inc. increased its stake in Omega Healthcare Investors by 1.7% in the third quarter. Assetmark Inc. now owns 1,191,460 shares of the real estate investment trust's stock worth $48,492,000 after purchasing an additional 19,542 shares during the period. Hedge funds and other institutional investors own 65.25% of the company's stock.

Omega Healthcare Investors Stock Performance

Shares of OHI traded down $0.13 during trading hours on Tuesday, reaching $41.26. 627,392 shares of the company traded hands, compared to its average volume of 1,666,199. The business has a fifty day moving average price of $40.62 and a 200-day moving average price of $36.47. The company has a quick ratio of 6.48, a current ratio of 6.48 and a debt-to-equity ratio of 1.10. Omega Healthcare Investors, Inc. has a 12-month low of $27.53 and a 12-month high of $44.42. The stock has a market capitalization of $11.14 billion, a P/E ratio of 30.43, a P/E/G ratio of 1.33 and a beta of 0.99.

Omega Healthcare Investors Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Monday, November 4th will be issued a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a dividend yield of 6.50%. The ex-dividend date is Monday, November 4th. Omega Healthcare Investors's dividend payout ratio is currently 197.06%.

Insider Buying and Selling

In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the business's stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the sale, the chief operating officer now owns 100,000 shares of the company's stock, valued at $4,025,000. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now owns 183,076 shares of the company's stock, valued at $7,357,824.44. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Daniel J. Booth sold 56,725 shares of the company's stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the transaction, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

OHI has been the topic of a number of research analyst reports. Royal Bank of Canada upped their price target on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a "sector perform" rating in a report on Monday. Wells Fargo & Company restated an "overweight" rating and set a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Mizuho lowered Omega Healthcare Investors from an "outperform" rating to a "neutral" rating and raised their price target for the company from $34.00 to $35.00 in a research note on Thursday, July 25th. Scotiabank upped their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "sector perform" rating in a research note on Monday, August 26th. Finally, BNP Paribas upgraded shares of Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 target price for the company in a report on Thursday, October 31st. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat, Omega Healthcare Investors currently has a consensus rating of "Hold" and a consensus price target of $40.00.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.